Evidence map›Paper›PMID 38512795›Full record

ArticleMMWR. Morbidity and mortality weekly report2024

Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis During the COVID-19 Pandemic - United States, 2019-2021.

Samantha L Williams, Dallas J Smith, Kaitlin Benedict, Jamie R Ahlers, Connie Austin, Rachael Birn, Angel M Carter, Natalie N Christophe, Katie Cibulskas, Paul R Cieslak and 18 more

Open access · diamondAbstract read
In one paragraph

Article in MMWR. Morbidity and mortality weekly report, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Microbiology and molecular biology reviews : MMBR · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Concurrent Histoplasmosis & Blastomycosis in a Young Woman.Journal of community hospital internal medicine perspectives · 2025
    Article
  15. Perspectives on blastomycosis in Canada in the face of climate change.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2024
    Article
  16. Disseminated Blastomycosis.The American journal of tropical medicine and hygiene · 2024
    Article
  17. Article
  18. Article
  19. Utility of Cytology of Spontaneously Expectorated Sputum Samples in the Diagnosis of Blastomycosis in Dogs.Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)
    Article
  20. Invasive Fungal Disease in Solid Organ and Hematopoietic Cell Transplant Recipients, United States.Transplant infectious disease : an official journal of the Transplantation Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 1 institution in 1 country.

Samantha L Williams
Dallas J Smith
Kaitlin Benedict
Jamie R Ahlers
Connie Austin
Rachael Birn
Angel M Carter
Natalie N Christophe
Katie Cibulskas
Paul R Cieslak
Suzanne N Gibbons-Burgener
Michael Gosciminski
Malia J Ireland
Katelyn V Lazenby
Tom Loftus
Kristy Lunquest
Abby A Mathewson
Alyssa D Nguyen
Hanna N Oltean
BreAnne Osborn
Erin M Petro
Danny J Power
Rebecca R Reik
Levi Schlosser
Judi Sedivy
Chad B Smelser
Tom Chiller
Mitsuru Toda
Mucolipidosis IV Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coccidioidomycosis, histoplasmosis, and blastomycosis are lower respiratory tract fungal infections whose signs and symptoms can resemble those of other respiratory illnesses, including pneumonia caused by bacterial or viral etiologies; this overlap in clinical presentation might lead to missed or delayed diagnoses. The causative fungi live in the environment, often in soil or plant matter. To describe the epidemiologic characteristics of cases of coccidioidomycosis, histoplasmosis, and blastomycosis during the COVID-19 pandemic, CDC analyzed case surveillance data for 2019-2021. During this period, a total of 59,655 coccidioidomycosis cases, 3,595 histoplasmosis cases, and 719 blastomycosis cases were reported to CDC. In 2020, fewer cases of each disease occurred in spring compared with other seasons, and most cases occurred in fall; national seasonality is not typically observed, and cases were seasonally distributed more evenly in 2019 and 2021. Fewer cases coinciding with the start of the COVID-19 pandemic, along with an unusually high blastomycosis case fatality rate in 2021 (17% compared with more typical rates of 8%-10%), suggest that the pandemic might have affected patients' health care-seeking behavior, public health reporting practices, or clinical management of these diseases. Increased awareness and education are needed to encourage health care providers to consider fungal diseases and to identify pneumonia of fungal etiology. Standardized diagnostic guidance and informational resources for fungal testing could be incorporated into broader respiratory disease awareness and preparedness efforts to improve early diagnosis of coccidioidomycosis, histoplasmosis, and blastomycosis.

Indexed as

BlastomycosisCoccidioidomycosisCOVID-19HistoplasmosisRespiratory Tract InfectionsHumansPandemicsUnited States

Identifiers

PMID38512795
PMCPMC10967682
OpenAlexW4393055417

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.